<DOC>
	<DOCNO>NCT00295217</DOCNO>
	<brief_summary>The goal study validate new ExAblate Application software V4.2 develop additional data show safety treatment . The ExAblate intend ablate uterine fibroid tissue pre- peri-menopausal woman symptomatic uterine fibroid desire uterine sparing procedure . Patients must uterine size le 24 week seek treatment reason improve fertility .</brief_summary>
	<brief_title>MR Guided Focused Ultrasound Surgery Treatment Uterine Fibroids : Software V4.2 Validation</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>1 . Women present symptomatic uterine fibroid seek treatment reason improve fertility . 2 . Able willing give consent able attend study visit . 3 . Patient pre perimenopausal ( within 12 month last menstrual period ) . 4 . Able communicate sensation ExAblate procedure . 5 . Uterine fibroid , device accessible ( i.e. , position uterus access without shielded bowel bone ) . 6 . Fibroids ( ) clearly visible noncontrast MRI . 1 . Metallic implant incompatible MRI 2 . Sensitive MRI contrast agent 3 . Severe claustrophobia would prevent completion procedure MR unit 4. Who pregnant desire become pregnant future . Pregnancies follow ExAblate treatment could dangerous mother fetus . 5 . Pedunculated fibroid 6 . Active pelvic inflammatory disease ( PID ) 7 . Active local systemic infection 8 . Known suspected pelvic carcinoma premalignant condition , include sarcoma adenomatous hyperplasia 9 . Intrauterine device ( IUD ) anywhere treatment path 10 . Dermoid cyst ovary anywhere treatment path 11 . Extensive abdominal scarring avoid redirection beam ( e.g. , due Caesarean section repeat abdominal surgery ) 12 . Undiagnosed vaginal bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Fibroids</keyword>
	<keyword>Uterine Leiomyomas</keyword>
	<keyword>ExAblate</keyword>
	<keyword>MrgFUS</keyword>
</DOC>